background

Basic Info

Adjutor Group, with Adjutor Healthcare and Adjutor Clinical sectors, is an Australia-based healthcare consultancy dedicated to fast‐tracking the development, registration, and commercialisation of innovative medicines and medical technology products across international markets. With a strong presence in Australia, New Zealand, and Hong Kong, and an established network of trusted partners worldwide, Adjutor provides clients with a single point of entry to major markets including Asia‐Pacific, North and Latin America, and the EU/UK.

Founded on more than a decade of consulting experience, Adjutor combines deep regulatory, clinical, quality, and commercial expertise to support medicines, medical devices, combination products, and advanced therapies such as cell and gene therapies. The team has successfully supported the registration of hundreds of medicines and medical devices across all classes, guiding clients through complex regulatory pathways while optimising time, cost, and risk.

Adjutor delivers end‐to‐end consultancy services spanning product development strategy, clinical development, regulatory affairs, quality management systems, training, sponsorship, and post‐market lifecycle management. Its regulatory services include gap analyses, dossier writing, submission management, regulatory agency interactions, GMP and ISO audits, and ongoing compliance support before and after approval. Through local legal entities, Adjutor can also act as product sponsor in selected markets, enabling efficient submissions and commercial supply.

Clinical CRO services is provided across multiple regions, from early strategy and feasibility through to operational trial management, safety reporting, data analysis, and study reporting. Adjutor’s quality and training services help clients build robust, compliant systems that meet global standards and stand up to regulatory scrutiny.

We operates as a true strategic partner rather than a traditional service provider. Adjutor works closely with innovators, biotech companies, and investors to overcome regulatory and commercial hurdles, support due diligence activities, and position products for long‐term success.

By combining global reach with local expertise and a proven network, the Adjutor Group helps clients unlock global markets and confidently bring high‐quality healthcare products to patients worldwide. (more information: www.adjutor.com.au )

Why work with us

We understand SMEs and the Adjutor Advantage is how we demonstrate, every day, that we are a great partner for your business. We're engaged, and motivated to help you at each stage of your journey to market and beyond.

Clients (8)

Moderna

Moderna Therapeutics is a biotech company revolutionizing medicine with mRNA therapeutics, producing human proteins inside patient cells to address undruggable targets and offer superior alt... read more

Menarini Asia

Medison Pharma

Medison Pharma is a global pharmaceutical organization dedicated to enhancing access to innovative therapies in international markets by partnering with emerging biotech firms to facilitate ... read more

MEDICE

Brochure

Company focus

Services

Contact Research Organisation (CRO)
Clinical Trial Management and Support
Industry Service Provider
Licensing/Technology Transfer
Therapeutics
Advanced therapies including cell & gene
Medicines
Vaccines
Medical Technology & Digital Health
Medical Product

Industries

Biotechnology
Chemicals
Pharmaceuticals
Research

Contacts

Deb Cooper Avatar

Deb Cooper

COO